IREN Limited filed a prospectus supplement on August 4, 2026, registering up to 11,981,668 ordinary shares for resale by selling shareholders who received those shares in connection with the company's merger with Mirantis, Inc., which closed on August 3, 2026.

Key Highlights

  • Shares registered for resale: Up to 11,981,668 ordinary shares are covered by the prospectus supplement.
  • Merger closed: The Agreement and Plan of Merger among IREN Limited, Kube Merger Sub Inc., and Mirantis, Inc., dated May 4, 2026, closed on August 3, 2026.
  • No proceeds to IREN: According to the filing, IREN will not receive any proceeds from the sale of ordinary shares by the selling holders.
  • Last reported share price: On August 3, 2026, the last reported sale price of ordinary shares was $39.75 per share.
  • Registration costs: The filing states that IREN will bear all costs, expenses, and fees in connection with the registration of these ordinary shares.
  • Listing: Ordinary shares are listed on the Nasdaq Global Select Market under the symbol "IREN."

IREN Registers Mirantis Merger Shares for Selling Holders

IREN Limited (NASDAQ: IREN) filed a prospectus supplement under Rule 424(b)(7) on August 4, 2026, covering the offer and resale of up to 11,981,668 ordinary shares. According to the filing, these shares are held by certain selling shareholders who received them in connection with the merger between IREN Limited, Kube Merger Sub Inc., and Mirantis, Inc. The merger agreement was dated May 4, 2026, and closed on August 3, 2026. The registration was made to satisfy registration rights IREN granted to those selling holders under the merger agreement.

The filing makes clear that IREN is not selling any securities itself and will not receive any proceeds from resales conducted under the prospectus supplement. Any shares subject to resale will have been issued by IREN and received by the selling holders prior to any such resale. IREN also stated it will bear all costs and expenses related to the registration and will not pay any underwriting discounts or commissions in connection with offerings under the supplement.

The selling holders may offer shares at fixed prices, at prevailing market prices, at prices related to prevailing market prices, at varying prices, or at privately negotiated prices, according to the filing. Sales may occur through underwriters, broker-dealers, or agents. The filing notes that registration of the shares does not mean the selling holders will offer or sell any of them. The prospectus supplement incorporates by reference a risk factors section beginning on page S-5, and the filing cautions that investing involves "a high degree of risk." Any forward-looking statements in the filing are the company's own and subject to its cautionary language.

What Was Disclosed

IREN Limited registered up to 11,981,668 ordinary shares for resale by former Mirantis, Inc. shareholders following the close of a merger on August 3, 2026. IREN will not receive proceeds from any resales and will cover registration costs.